Hyperfine (HYPR) and the All India Institute of Medical Sciences, AIIMS, New Delhi announced that AIIMS New Delhi has initiated clinical use of the Swoop portable MRI system. “Bedside brain imaging transforms how we care for our most critically ill patients. At AIIMS, we manage thousands of stroke and ICU patients annually, where rapid neuroimaging is essential-yet transport to conventional MRI is often unsafe or impossible. The Swoop(R) system eliminates that barrier. Now our clinicians can obtain diagnostic images at the point of care, enabling faster decision-making in neurology, trauma, and critical care. For a medical institution like ours that serves as a referral center across India, this deployment signals what’s possible when technology and clinical need align to advance neurological care,” said Dr. Shailesh Gaikwad, Head, Department of Neuroimaging and Interventional Neuroradiology and Chief of Neuroscience Centre AIIMS New Delhi.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR:
- Hyperfine initiated with a Buy at BTIG
- Hyperfine receives CE Marking, UK Conformity Assessment approval
- Hyperfine’s Portable MRI Trial Update Puts Contrast Imaging in the Spotlight
- Horizon Technology provides $40M loan facility to Hyperfine
- Hyperfine Inc. Exposed to Rising Credit Risk as Delayed Customer Payments Threaten Cash Flow and Financial Stability
